How many key informants are enough? Analysing the validity of the community readiness assessment.

Assessment Community readiness Community-based health promotion Key informants Validity

Journal

BMC research notes
ISSN: 1756-0500
Titre abrégé: BMC Res Notes
Pays: England
ID NLM: 101462768

Informations de publication

Date de publication:
09 Mar 2021
Historique:
received: 16 09 2020
accepted: 23 02 2021
entrez: 22 3 2021
pubmed: 23 3 2021
medline: 15 5 2021
Statut: epublish

Résumé

Communities are important settings for health promotion and prevention. The community readiness assessment offers a structured approach to assess resources and opportunities to tackle a health problem within a community. The assessment relies on semi-structured interviews with key informants from the communities. A number of 4-6 key informant interviews are recommended in the literature. However, it is unclear whether this is sufficient to obtain a valid representation of the respective community. This study analysed whether increasing the number of key informants from 4-6 to 12-15 alters the results of the community readiness assessment. A total of 55 community readiness interviews were carried out in 4 communities. Overall, the community readiness scores showed little variation after having interviewed 10 key informants in a community. However, even after completing 10 interviews in a community, key informants were still able to identify up to 6 new information items regarding community efforts for physical activity promotion among the elderly, contact and communication channel for informing or approaching the target group, or barriers to participation.

Identifiants

pubmed: 33750436
doi: 10.1186/s13104-021-05497-9
pii: 10.1186/s13104-021-05497-9
pmc: PMC7941941
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

85

Subventions

Organisme : Bundesministerium für Bildung und Forschung
ID : 01EL1822A

Références

Appl Health Econ Health Policy. 2008;6(4):173-87
pubmed: 19382818
Int J Environ Res Public Health. 2015 Mar 24;12(4):3453-68
pubmed: 25811769
BMC Public Health. 2016 Feb 01;16:99
pubmed: 26833206
BMC Public Health. 2019 Oct 30;19(1):1420
pubmed: 31666042
BMC Public Health. 2013 Dec 20;13:1205
pubmed: 24359213
Glob Health Promot. 2020 Mar;27(1):59-67
pubmed: 30319018
Qual Health Res. 2017 Mar;27(4):591-608
pubmed: 27670770
Health Expect. 2019 Jun;22(3):575-584
pubmed: 30972905
J Community Psychol. 2017 May;45(4):486-499
pubmed: 28458405
Gesundheitswesen. 2020 Nov;82(11):868-876
pubmed: 32344445
BMC Public Health. 2019 May 28;19(1):646
pubmed: 31138180
Annu Rev Public Health. 2006;27:297-322
pubmed: 16533119
Transl Behav Med. 2020 Feb 3;10(1):114-122
pubmed: 31330011
Psychol Health. 2010 Dec;25(10):1229-45
pubmed: 20204937
Health Soc Care Community. 2015 May;23(3):262-71
pubmed: 25429845
Int J Environ Res Public Health. 2018 Mar 06;15(3):
pubmed: 29509675

Auteurs

Saskia Muellmann (S)

Department of Prevention and Evaluation, Leibniz-Institute for Prevention Research and Epidemiology - BIPS, Achterstr 30, 28359, Bremen, Germany.

Tilman Brand (T)

Department of Prevention and Evaluation, Leibniz-Institute for Prevention Research and Epidemiology - BIPS, Achterstr 30, 28359, Bremen, Germany.

Dorothee Jürgens (D)

Department of Prevention and Evaluation, Leibniz-Institute for Prevention Research and Epidemiology - BIPS, Achterstr 30, 28359, Bremen, Germany.

Dirk Gansefort (D)

Department of Prevention and Evaluation, Leibniz-Institute for Prevention Research and Epidemiology - BIPS, Achterstr 30, 28359, Bremen, Germany.
Association for Health Promotion and Academy of Social Medicine Lower Saxony, Fenskenweg 2, 30165, Hannover, Germany.

Hajo Zeeb (H)

Department of Prevention and Evaluation, Leibniz-Institute for Prevention Research and Epidemiology - BIPS, Achterstr 30, 28359, Bremen, Germany. zeeb@bips.uni-bremen.de.
Health Sciences Bremen, University of Bremen, Bremen, Germany. zeeb@bips.uni-bremen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH